Singapore: UK-based contract organization TranScrip Partners launched its operations in Australia. TranScrip Partners supports biopharmaceutical product development and life cycle management globally and work for more than 50 companies across four continents.

TranScrip Partners challenge the traditional CRO model by offering to clients, on a global basis, top level expertise and previous experience in overcoming the hurdles, encountered from translational medicine to successful registration and market access. The launch of the Australian office marks a relevant and important milestone in the expansion of TranScrip Partners.

"This provides a tremendous opportunity to bring the breadth and depth of top level expertise and experience of the global team of TranScrip Partners to the highly innovative biotech and pharmaceutical companies here in Australia and Asia Pacific," commented Dr Bernadette Morris-Smith, who heads the Australian office.

Dr Morris-Smith added that "Australia is home to many discoveries which have had a global impact. Australia offers a cost effective solution to clinical trial recruitment and an efficient and transparent regulatory system".

TranScrip Partners are "strategic thinkers who do, and doers who think strategically" says founding and managing partner, Dr Flic Gabbay. Services offered by TranScrip Partners include development and market positioning strategies for early molecules as well as tailored support in drug development, medical monitoring, pharmacovigilance, strategic regulatory affairs and medical writing across a range of therapy areas.